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Background: MCM2-7 loading onto chromatin 
licenses origins for replication. 
Results: MCMs exhibit transient interactions with 
chromatin in late mitosis, stable binding in G1, 
and increased loading in late G1. 
Conclusion: Multi-level regulation of MCM2-7 
loading to chromatin occurs during mitosis and 
preceding the G1/S phase transition. 
Significance: The dynamics of the DNA licensing 
system within live human cells reveal multiple 
control points. 
 
SUMMARY   
Once-per-cell cycle replication is regulated 
through the assembly onto chromatin of multi-
subunit protein complexes which license DNA 
for a further round of replication. Licensing 
consists of the loading of the hexameric MCM2-
7 complex onto chromatin during G1, and is 
dependent on the licensing factor Cdt1. In vitro 
experiments have suggested a two-step binding 
mode for MCM proteins, with transient initial 
interactions converted to stable chromatin 
loading. Here, we assess MCM loading in live 
human cells, using an in vivo licensing assay 
based on Fluorescence Recovery After 
Photobleaching (FRAP) of GFP tagged MCM 
protein subunits through the cell cycle. We 
show that in telophase, MCM2 and MCM4 
maintain transient interactions with chromatin, 
exhibiting kinetics similar to Cdt1. These are 
converted to stable interactions from early G1 
phase. The immobile fraction of MCM2 and 
MCM4 increases during the G1 phase, 
suggestive of reiterative licensing. In late G1 
phase, a large fraction of MCM proteins are 
loaded onto chromatin, with maximal licensing 
observed just prior to S-phase onset. 
Fluorescence Loss In Photobleaching (FLIP) 
experiments show subnuclear concentration of 
MCM-chromatin interactions which differ as 
G1 progresses and do not co-localize with sites 
of DNA synthesis in S phase.  
Faithful DNA replication is a prerequisite for 
the preservation of genomic information. In 
eukaryotic cells, DNA replication initiates from 
multiple replication origins distributed on 
chromosomes, which direct the assembly of 
multiprotein complexes (known as “replisomes”), 
which will move along with each replication fork 
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(1-4). The DNA replicated by sister forks from a 
single origin is called a replicon. It has been 
proposed that in eukaryotic cells the DNA 
replication machinery is restrained at specific 
nuclear structures called “replication factories”, 
which exhibit dynamic behavior as they assemble 
and disassemble in space during S phase ((5-8), 
reviewed in (9,10)). Sister replication forks 
generated from the same origin are believed to 
remain associated within a replication factory 
while the entire replicon is replicated (11). 
Replication begins in nuclear euchromatin at 
approximately 100-300 foci (visualized after BrdU 
or PCNA staining) distributed throughout the 
nucleus. During mid S phase, these foci are 
located in heterochromatic regions near the 
nuclear periphery and surrounding the nucleoli, 
while in late S phase, only a few intense and larger 
replication foci are located at the nuclear periphery 
and within the nucleoli (6-10).  
DNA replication must be limited to only once 
per cell cycle, so as to prevent re-replication and 
maintain genomic stability (reviewed in (12-14)). 
The integrity of genomic information is preserved 
through the periodic assembly and disassembly of 
essential pre-replication complexes (pre-RCs) at 
replication origins. This process, described as 
chromatin “licensing”, involves the loading of the 
heterohexameric MCM2-7 (minichromosome 
maintenance) protein complex onto chromatin by 
the origin recognition complex (ORC) and two 
essential loading factors, Cdc6 (15) and Cdt1 
(16,17). Licensing ensures the faithful regulation 
of DNA replication in time and space (18). The 
eukaryotic cell cycle is driven by the periodic 
activation and inactivation of cyclin-dependent 
kinases (CDKs) that allow pre-RC formation to 
occur in a time window between late mitosis 
through G1 phase, during which Cdk/cyclin levels 
are low due to the anaphase promoting 
complex/cyclosome (APC/C) and cyclin 
dependent kinase inhibitors (CKIs) (14). In 
metazoa, licensing is additionally controlled 
through Geminin (19), a protein which binds to 
Cdt1 and inhibits it from loading the MCM 
complex onto chromatin during S and G2 phases 
(20-22). The timing and extent of MCM loading 
onto chromatin must be accurately controlled 
through the cell cycle and co-ordinated with S-
phase onset: both under-licensing and over-
licensing have been linked to DNA replication 
stress, genomic instability and malignant 
transformation (23-25). 
MCM2-7 proteins belong to the AAA ATPase 
family. They adopt a hexameric ring-like structure 
(26-28), large enough to accommodate ssDNA or 
dsDNA (27-30), and are considered the prime 
candidates for the eukaryotic replicative helicase 
(31). The spatial localization of MCMs after the 
onset of DNA replication, during which MCM 
proteins bind preferentially to unreplicated DNA, 
rather than to replicating or replicated DNA 
(32,33), as well as the excess number of MCM2-7 
complexes loaded per ORC (34,35) raise questions 
on MCM function that are put together as the 
“MCM paradox”. In vitro studies in yeast support 
a two-step model for the loading of the MCM2-7 
complex onto chromatin (36-38). MCM proteins 
firstly bind transiently onto origin DNA and are 
then loaded stably in a step requiring ATP 
hydrolysis by cdc6 (39). The MCM2-7 complex is 
loaded in an inactive form at origins. As cells enter 
S phase the combined action of CDKs and Cdc7-
Dbf4 (reviewed in (40)) leads to the formation of a 
complex between MCM2-7, Cdc45 and GINS 
(CMG complex) (41), which bears processive 
helicase activity (42) and is part of the replisome 
(43,44).   
Live cell imaging studies revealed both ORC 
(45) and Cdt1 (46,47) to be highly mobile within 
the cell nucleus, while a recent study showed 
stable binding of MCM proteins throughout G1 
and S phase in Chinese Hamster Ovary (CHO) 
cells (48). Here, we use live-cell imaging to assess 
MCM chromatin loading at different cell cycle 
stages of human cancer cells. Our analysis reveals 
transient interactions of MCM proteins with 
chromatin in telophase, followed by stable binding 
during G1. In addition, we show that in late G1 
phase the fraction of MCM proteins which are 
bound to chromatin is markedly increased, 
suggesting that chromatin is only fully licensed in 
late G1. Our findings suggest multiple levels of 
regulation of MCM binding to chromatin within 
the live cell nucleus, taking place during both 
mitosis and at the G1 to S phase transition. 
 
EXPERIMENTAL PROCEDURES 
Cell culture, isolation of stable cell lines, cell 
synchronization and transfection, FACS analysis - 
MCF7 cells were grown in Dulbecco’s modified 
Eagle’s medium with 20% fetal bovine serum at 
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37oC and 5% CO2. For live-cell experiments, cells 
were plated on MatTek dishes (MatTek 
Corporation) in phenol red-free, CO2-independent 
medium (Invitrogen). Stable GFP-NLS, GFP-
MCM2 and GFP-MCM4 cell lines were selected 
with 500 g/ml Geneticin (Invitrogen). Stable 
Cdt1-GFP cell line generation and characterization 
have been previously described (47). For transient 
transfection, MCF7 cells plated in 35 mm dishes 
were transfected with a total of 1 μg of plasmid 
DNA for 24 hours using Lipofectamine 2000 
(Invitrogen) or Turbofect (Fermentas) according to 
the manufacturer’s instructions. For Cdt1 
silencing, MCF7 stable cell lines were transfected 
with 400 nM of Cdt1 siRNA or control Luciferase 
siRNA using Lipofectamine 2000 twice, with a 
time interval of 24 hours and analyzed 48 hours 
following the second transfection.  
For mitotic synchronization, cells were treated 
either with 40 ng/ml nocodazole (Sigma) for 12 
hours or with 100 μM monastrol (Sigma) for 16 
hours, collected by mechanical shake off and 
released into fresh medium. For late G1 
synchronization, cells were grown in the presence 
of 0.5 mM mimosine (Sigma) for 24 hours. The 
synchronization in early S phase was performed 
with a double thymidine block (2.5 mM, Sigma) or 
with 5 mM Hydroxyurea (Sigma) treatment for 24 
hours. 
For FACS analysis, stable GFP-NLS, GFP-
MCM2 and GFP-MCM4 cell lines, as well as 
parental MCF7 cells were fixed with 70% ice-cold 
ethanol and stained with propidium iodide (2 g 
/ml) in the presence of 100 g/ml RNase, in PBS. 
Cellular DNA content was analyzed using a 
Becton Dickinson flow cytometer with Cellquest 
software and WinMDi software version 2.8. 
Immunofluorescence, Western blotting, 
Immunoprecipitation - Immunofluorescence was 
done as previously described (49). Primary 
antibodies used: α-MCM2 (BD Transduction) 
1:500, α-MCM4 (BD Pharmingen) 1:600, α-Cdt1 
(50) 1:250, α-Geminin (47) 1:250, α-Cyclin A 
(Neomarkers) 1:100. DNA was stained with 
Hoechst 33258 (Sigma), DAPI (Vector) or TOTO-
3 (Molecular Probes).  
For western blotting, total cell lysates were 
prepared by lysing cell pellets directly in SDS-
PAGE loading buffer. Primary antibodies used: α-
MCM2 (BD Transduction) 1:1000, α-MCM4 (BD 
Pharmingen) 1:6000, α-MCM7 (Santa Cruz) 
1:500, α-Cdt1 (50) 1:250, α-GFP (Roche) 1:6000, 
α-tubulin (Sigma) 1:20000.  
For immunoprecipitation experiments, total 
cell lysates from asynchronous MCF7 cells as well 
as from GFP-MCM2, GFP-MCM4 and GFP-NLS 
stable cell lines were prepared by using a lysis 
buffer containing 50 mM Tris-HCl pH 7.6, 150 
mM NaCl, 5 mM EDTA, 5 mM MgCl2, 0.5% 
Triton X-100, 1 mM phenylmethylsulfonyl 
fluoride and complete, EDTA-free Protease 
Inhibitor Cocktail Tablets (Roche). GFP-tagged 
proteins were immunoprecipitated using anti-GFP 
antibodies (mouse monoclonal anti-GFP, 3E6, 
1181460001, Roche) bound to protein G agarose 
beads (Upstate). Immunoprecipitates were 
analyzed by western blotting. 
Chromatin association assay - About 5x105 
cells were washed with ice-cold PBS buffer and 
lysed in 0.1 ml of 0.1% TX-100 mCSK buffer (10 
mM Pipes, pH 7.9, 100 mM NaCl, 300 mM 
sucrose, 0.1 (v/v)% Triton X-100, 1 mM 
phenylmethylsulfonyl fluoride, 10 mM β-
glycerophosphate, 1 mM Na3VO4, 10 mM NaF), 
for 15 minutes on ice. After centrifugation at 
13,000 rpm for 15 minutes at 4°C, the supernatant 
that was isolated represented the soluble fraction 
(S100). The pellet was washed with equal volume 
of ice-cold 0.1% TX-100 mCSK buffer and 
suspended in SDS sample buffer (chromatin 
enriched fraction - P100). 
Plasmids - To fuse GFP to the N-terminus of 
MCM2 and MCM4, the open reading frames of 
MCM2 and MCM4 (kindly provided by Dr. A 
Perrakis) were subcloned into pCDNA3.1/EGFP 
(Invitrogen) between the EcoRI and XhoI sites. 
PCNA tagged to mRFP (PCNA-RFP) was kindly 
provided by Dr C. Cardoso (51). A GFP-nls 
construct was generated by cloning three copies of 
the SV40 nuclear localization sequences at the C-
terminus of the GFP sequence in pEGFP-C1 
vector.  
Photobleaching experiments and analysis – 
Photobleaching experiments were performed on a 
Leica TCS SP5 confocal microscope equipped 
with a 63x 1.4 NA oil immersion lens. During 
experiments cells were maintained at 37°C and 5% 
CO2. For Fluorescence Recovery after 
Photobleaching (FRAP) experiments, bleaching 
was accomplished on a defined region of interest 
of 2 μm diameter, within the cell nucleus. Fifty 
prebleach images were recorded with 3% laser 
Maximal loading of MCM2/4 in late G1 
 
 4
power of the 488 nm line at 70% argon laser 
intensity and bleaching was attained by a double 
bleach pulse of 0.066 seconds using the 458, 476, 
488 and 496 nm laser lines combined at maximum 
power. Following bleaching, 250 images were 
recorded at 0.066 seconds intervals with 3% laser 
power of the 488 nm line. Raw data were 
normalized as previously described (47). Immobile 
fractions and t1/2 values were extracted after a 
double exponential fitting using the program 
easyFRAP (52) and the FRAPcalcV9j application 
of Dr Kota Miura (EMBL). 
Fluorescence Loss in Photobleaching (FLIP) 
experiments were performed by repeatedly 
bleaching a specified region within the cell 
nucleus. In Figures 7A, a circular region of 4 m 
in diameter within the cell nucleus was repeatedly 
bleached with 60 pulses using the 458, 476, 488 
and 496 nm laser lines combined at maximum 
power, In figure 7C a region corresponding to 
approximately 1/3 of the nucleus was bleached as 
above. In Figure 7B, about 1/3 of the cell nucleus 
was bleached with 150 pulses using the 476 and 
488 nm laser lines combined at 70% laser intensity 
using a FRAP-booster (Leica TCS SP5 Confocal 
Microscope). Following FLIP, confocal images 
were recorded to visualize immobile structures of 
GFP-MCM2 within the nucleus. In Figure 8, the 
redistribution of fluorescence was monitored by 
acquiring a series of 10 optical sections along the z 
axis of each cell, at 5-minute intervals over a 
period of 2 hours.  
Quantification and image analysis - siRNA-
mediated depletion of Cdt1 was estimated by 
quantifying mean fluorescence intensities of cells 
subjected to immunofluorescence with anti-Cdt1 
antibody using ImageJ 1.37g (Wayne Rasband, 
National Institute of Mental Health, Bethesda, 
MD).  
For each cell subjected to FLIP in Figure 8, 
the maximum projection of the z-stacks was 
quantified and a linear filter was applied to remove 
noise and smoothen the image, by setting the 
intensity value of each pixel to the average of the 
pixels in its 6 x 6 neighbourhood. The 
corresponding data are shown as mesh plots. The 
analysis was performed using MATLAB R2007b. 
 
RESULTS 
A system for studying MCM protein dynamics 
within live human cells - In order to study the 
dynamics of MCM proteins within live human 
cells, the MCM2 and MCM4 proteins were fused 
to green fluorescent protein (GFP) at their N-
termini (GFP-MCM2 and GFP-MCM4). MCM4 
was chosen as it was shown to interact with the 
GINS complex (42) and its phosphorylation by 
Cdc7 facilitates the interaction with Cdc45 on 
chromatin (53). MCM2, as well as MCM3, carry 
nuclear localization sequences (NLS) sequestering 
the other MCM subunits to the cell nucleus (54). 
The GFP-MCM2 and GFP-MCM4 constructs, 
under the control of the constitutive CMV 
promoter, were used for transient expression in 
MCF7 human breast cancer cells. GFP-MCM2 
localized to the nucleus and was excluded from the 
nucleoli, similar to endogenous MCM2 (data not 
shown). GFP-MCM4 transiently expressed 
showed both nuclear and occasional cytoplasmic 
localization (data not shown), consistent with 
previous results showing that MCM4 lacks a 
nuclear localization signal and is transported to the 
nucleus in complex with other subunits (48,54). 
Several MCF7 cell lines stably expressing GFP-
MCM2, GFP-MCM4 or a nuclear localized 
construct of GFP (GFP-NLS) were generated and 
analysed by GFP fluorescence and western blot 
analysis (data not shown). Clonal cell lines 
expressing the tagged proteins at levels similar to 
the endogenous MCM2 and MCM4 respectively 
were selected for further analysis (Figure 1A). In 
figures 1B and 1C, GFP fluorescence in the stable 
cell lines is compared to immunofluorescence 
using anti-MCM2 and anti-MCM4 specific 
antibodies. Both GFP-MCM2 (Figure 1B) and 
GFP-MCM4 (Figure 1C) exhibited the same 
subcellular localization as the endogenous 
proteins, localizing to the nucleus and being 
excluded from the nucleoli. This analysis further 
verified the low-level expression of the tagged 
moieties, as no increase in total anti-MCM2 and 
anti-MCM4 staining was observed in the stable 
cell lines, and indicated correct complex formation 
of GFP-MCM4 expressed to low levels, allowing 
its correct localization to the nucleus. To verify 
that the constitutive expression of the tagged 
MCM2 and MCM4 moieties, even at low levels, 
did not interfere with correct cell cycle 
progression, the cell cycle profiles of the stable 
cell lines were compared to the parental MCF7 
cell line. Fluorescence-activated cell sorter 
(FACS) analysis of the stable cell lines produced 
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cell-cycle profiles similar to the parental MCF7 
cells (Figure 1D). This finding was further 
confirmed by immunofluorescence against 
different cell-cycle markers: the percentage of 
cells in GFP-MCM2, GFP-MCM4 and GFP-NLS 
expressing cell lines which were positive for Cdt1 
(G1 marker), Geminin (S-G2 marker) and Cyclin 
A (S-G2 marker) was similar to those of the 
control MCF7 cells (Figure 1E).  
We then addressed whether GFP-MCM2 and 
GFP-MCM4 were able to interact and form 
complexes with the other endogenous MCM 
subunits of the MCM2-7 hexamer. Total cell 
extracts from GFP-MCM2, GFP-MCM4 and GFP-
NLS (as negative control) stable cell lines were 
immunoprecipitated using an anti-GFP antibody 
and immunoprecipitates analyzed by western 
blotting using specific antibodies for MCM2, 
MCM4 and MCM7. As shown in figure 1F, both 
GFP-MCM2 and GFP-MCM4 form complexes 
with the other endogenous MCM subunits.  
To assess the ability of GFP-MCM2 and GFP-
MCM4 to associate with chromatin during the cell 
cycle, chromatin association assays were 
performed in mitotically synchronized cell 
populations. Cells were arrested in mitosis by 
nocodazole and mitotic shake-off, and time-points 
taken following release, as cells progressed 
synchronously in G1. As shown in figure 2A, 
GFP-MCM2, similar to endogenous MCM2, is 
expressed in mitosis and throughout G1, but 
associates with a chromatin enriched insoluble 
fraction following release into G1, in parallel to 
the chromatin association of Cdt1. Note the 
hypermodification of Cdt1 in mitotically arrested 
cells, as previously reported (55). Similarly, GFP-
MCM4 associated with chromatin during the G1 
phase, with kinetics similar to the endogenous 
MCM4 (Figure 2B). Note the hypermodification 
of both the endogenous MCM4 and GFP-MCM4 
in mitosis (as previously reported (56)), and the 
apparent decrease in their protein levels at the 
mitotic block, which point to regulation of MCM4 
in mitosis by post-translational modifications and 
proteolysis. Note also that Cdt1 chromatin 
association temporarily precedes MCM2 and 
MCM4 chromatin association. These experiments 
confirm that both GFP tagged proteins associate 
with chromatin with kinetics similar to the 
endogenous ones.  
Taken together, the above results show that 
GFP-MCM2 and GFP-MCM4 functionally mimic 
the behavior of their endogenous counterparts, 
allowing their use for the investigation of the 
spatiotemporal regulation of the endogenous 
proteins in live human cells. 
Fluorescence recovery after photobleaching 
reveals an immobile MCM pool within the live-cell 
nucleus - Our previous work had shown that Cdt1-
GFP exhibits a scanning behavior during the G1 
phase of human cultured cells, maintaining 
dynamic short-lived interactions with chromatin 
throughout G1 (47). A similar dynamic behavior 
was also reported for Origin Recognition Complex 
(ORC) components (45). In contrast, a recent 
study showed stable binding of MCM proteins to 
chromatin in CHO cells (48). To investigate the 
behavior of MCM proteins in live human cells, 
real-time in vivo confocal fluorescence 
microscopy was used. Unsynchronized MCF7 
cells stably expressing GFP-MCM2, GFP-MCM4 
and GFP-NLS were subjected to Fluorescence 
Recovery after Photobleaching (FRAP). In 
parallel, MCF7 cells stable for Cdt1-GFP were 
analyzed for comparison (47). The mobility and 
kinetic properties of MCM2, MCM4 and Cdt1 
were assessed by photobleaching the GFP tagged 
proteins in a small circular region (2 μm in 
diameter) located inside the nucleus and then 
monitoring the recovery of fluorescence over time. 
Mean normalized curves derived from 15-50 
individual cells are shown in figure 3. Curve 
fitting of all individual recovery curves (52) was 
used to calculate the half-time (t1/2) of the 
fluorescence recovery and the fraction of 
molecules which were immobile (Imm. Frac.). 
Both MCM2 and MCM4 displayed rapid recovery 
kinetics during the first part of the recovery curve 
similar to that of the freely diffusing GFP-NLS, 
suggesting that a fraction of each protein is free to 
diffuse within the live cell nucleus. In contrast to 
GFP-NLS however, both proteins exhibited 
substantial immobile fractions, which showed no 
detectable recovery during the time-course of the 
experiment. This indicates that a substantial 
fraction of both GFP-MCM2 and GFP-MCM4 is 
immobile within the live cell nucleus. Our 
previous work had shown that Cdt1-GFP exhibited 
short-lived interactions with chromatin which 
delayed initial fluorescence recovery, leading to a 
longer t1/2 for Cdt1 than the GFP control (47). 
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Consistent with our earlier findings, Cdt1 
exhibited a substantially increased t1/2 in 
comparison to GFP-NLS (Figure 3). Direct 
comparison of the MCM and Cdt1 FRAP curves 
shows that MCM proteins exhibit a kinetic 
behavior which differs significantly from Cdt1: 
MCM proteins show fast initial recovery and a 
substantial immobile fraction, while Cdt1 shows 
reduced initial recovery and a much smaller 
immobile fraction. We conclude that MCM 
proteins maintain long-lived interactions within 
the nucleus in contrast to Cdt1. This is consistent 
with findings in CHO cells (48) and indicates that 
the majority of the MCM molecules do not move 
as a complex with Cdt1 within live human cells.  
Imaging MCM  dynamics within the nucleus: 
an in vivo licensing assay - To verify that the 
observed  immobile MCM pool represented 
MCM- chromatin association during licensing, we 
investigated whether the presence of an immobile 
MCM fraction was dependent on Cdt1, a factor 
essential for the loading of MCM proteins onto 
chromatin. We therefore knocked down Cdt1 
expression in MCF7 cells stable for GFP-MCM2 
and GFP-MCM4 using siRNA. The efficiency of 
the knock-down was assessed by quantitative 
immunofluorescence (data not shown). As shown 
in figure 4A, FRAP assays revealed that Cdt1 
depletion resulted in significantly reduced 
immobile fractions for GFP-MCM2 and GFP-
MCM4. In contrast, in cells treated with control 
siRNA, GFP-MCM2 and GFP-MCM4 retained an 
immobile fraction. We therefore conclude that the 
presence of an immobile MCM pool is Cdt1 
dependent and it is therefore likely to represent 
MCM-chromatin interactions during licensing.  
We then asked whether the observed immobile 
fraction of MCM proteins is cell cycle regulated, 
consistent with MCM chromatin binding during 
licensing. To address this question, GFP-MCM2 
and GFP-MCM4 expressing MCF7 cell lines were 
transiently transfected with proliferating cell 
nuclear antigen (PCNA) tagged with the red 
fluorescent protein (RFP). PCNA has been well 
established as a marker with characteristic cell-
cycle dependent nuclear patterns, exhibiting 
diffuse nuclear distribution in non-S phase cells 
and subnuclear focal accumulation in S phase cells 
(Figure 4B). By using this method of 
discrimination (7), cells at different cell cycle 
stages were identified and classified according to 
their pattern of PCNA as non-S, early S, middle S 
and late S, and analyzed by FRAP. Mean FRAP 
curves for GFP-MCM2 and GFP-MCM4 are 
shown in figures 4C and 4D, respectively. In both 
cases, the recovery half-time (t1/2) among the 
different cell cycle phases is similar and 
marginally increased compared to GFP-NLS. 
However, different immobile fractions were 
observed for both proteins during the course of the 
cell cycle. Non-S cells demonstrated an immobile 
fraction of about 22% for GFP-MCM2 and 19% 
for GFP-MCM4, whereas 30% of GFP-MCM2 
and GFP-MCM4 appeared to be immobile in early 
S phase cells, indicating stable binding of a 
substantial fraction of MCMs to chromatin at the 
onset of S phase. In middle to late S phase cells, 
the immobile fractions were decreased for both 
GFP-MCM2 and GFP-MCM4, demonstrating that 
both molecules dissociate from chromatin during 
the progression through S phase, consistent with 
licensing loss during S phase. 
These findings show that the presence of an 
immobile MCM pool, as measured by FRAP, 
closely mirrors MCM-chromatin association 
during licensing, consistent with earlier work (48). 
Our assay can therefore be used to assess licensing 
in vivo.   
MCM – chromatin association kinetics during 
the cell cycle reveal increased MCM loading in 
late G1 phase- We used the in vivo licensing assay 
to study MCM dynamics during the cell cycle of 
live human cells. Given that the previously 
analyzed non-S phase cell population represents a 
heterogeneous pool of cells in different stages of 
G1 as well as in G2 phase, we investigated MCM 
kinetic parameters exclusively during G1 phase 
and examined whether the association of MCM 
with chromatin changes as G1 phase progresses. 
To that end, MCF7 cells expressing GFP-MCM2 
or GFP-MCM4 were first synchronized in G2/M 
phase by nocodazole block and mitotic shake-off 
treatment, released into fresh medium and 
analyzed as they progressed synchronously 
through G1. The efficiency of the synchronization 
was verified by immunofluorescence using cell 
cycle markers (data not shown), showing that S-
phase entry occurred at 12-15 hours following 
nocodazole release. Cells were analyzed by FRAP 
at 3 hours (early G1 phase) and 9 hours (middle to 
late G1 phase) after release. As depicted in figures 
5A and 5B, both GFP-MCM2 and GFP-MCM4 
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exhibited a measurable immobile fraction already 
from early G1 (3 hours after nocodazole release, 
observed mean immobile fractions of 8% and 9%, 
respectively), consistent with stable chromatin 
association taking place for a small fraction of 
MCM proteins from early G1. In middle to late G1 
cells (9 hours after nocodazole release), the 
immobile fractions increased somewhat to a mean 
of 12% and 19%, respectively. This increasing 
trend is indicative of reiterative loading of MCMs 
onto chromatin during the course of G1 phase. 
Given the significant immobile fraction 
observed in early S phase cells through co-
transfection with PCNA (Figures 4C and 4D), we 
wished to directly compare MCM - chromatin 
association kinetics in late G1 with early S phase. 
For this purpose, MCF7 cell lines expressing 
either GFP-MCM2 or GFP-MCM4 were arrested 
in late G1 by treatment with mimosine and in early 
S phase by hydroxyurea or by double thymidine 
block. The efficiency of the arrest and the ability 
of cells to be released from each block were 
verified by immunofluorescence with specific cell 
cycle markers (PCNA, Geminin and cyclin A, data 
not shown). FRAP analysis showed that both GFP-
MCM2 and GFP-MCM4 exhibited the largest 
mean immobile fraction in late G1 (mimosine 
block, ~25-30%) while immobile fractions for 
both proteins were considerably lower in the early 
S phase blocks when compared to late G1 cells 
(Figures 5C and 5D). To verify that maximal 
loading of MCM proteins takes place in late G1 
phase, MCF7 cells stably expressing GFP-MCM2 
or GFP-MCM4 were synchronized in 
prometaphase by monastrol, which allows 
reversible mitotic arrest with synchronous entry 
into the following S phase upon release. BrdU 
incorporation and staining for Cdt1 was used to 
characterize progression through the cell cycle and 
showed that entry into S phase occurred 
synchronously 15 hours post release from 
monastrol. Therefore, cells analyzed by FRAP at 3 
hours, 7 hours and 13 hours post release were 
considered to be in early, middle and late G1 
phase, respectively.  As shown in figures 5E and 
5F, both GFP-MCM2 and GFP-MCM4 proteins 
exhibit maximal loading in late G1 phase (13 
hours post release from monastrol)  with 
substantially increased immobile fractions (~30-
40%) as compared to early and middle G1 phase 
(~15%). Taken together, these observations clearly 
indicate that while a fraction of MCM proteins is 
loaded onto chromatin from early G1 phase, the 
majority of MCM proteins are loaded in late G1 
phase, prior to the onset of DNA replication.    
MCM proteins exhibit dynamic interactions 
with chromatin during telophase - Our in vivo data 
so far indicates that MCM proteins maintain long-
lived interactions with chromatin throughout G1, 
with maximal chromatin association prior to the 
G1 to S phase transition. In vitro studies have 
shown that MCM protein loading takes place in 
two phases, with an initial transient association 
being converted to stable loading accompanied by 
ATP hydrolysis and dissociation of MCM loading 
factors. We therefore wished to investigate if we 
could detect such a transient MCM-chromatin 
association early in the cell cycle. Towards this 
aim, we studied cells in mitosis. We first 
characterized MCM co-localization with 
chromatin throughout mitosis. MCF7 cells stable 
for GFP-MCM4 were synchronized in G2/M with 
nocodazole, fixed at different time-points after the 
release and counterstained with DAPI to visualize 
chromatin. Cells in different stages of mitosis were 
identified. As shown in figure 6A, MCM4 
appeared to be excluded from chromosomes 
during prophase, metaphase and anaphase. In 
contrast, MCM4 was shown to overlap with 
DAPI-stained chromatin in cells undergoing 
telophase, as nuclear envelopes are reforming. 
This is similar to the behavior of Cdt1 during 
mitosis (47). Similar results were obtained for 
GFP-MCM2 (data not shown). 
To elucidate the chromatin association 
properties of MCMs during the different stages of 
mitosis, MCF7 cells stably expressing GFP-
MCM2 or GFP-MCM4 were transiently 
transfected with H2B-RFP, a protein that is stably 
associated with chromatin enabling the 
observation of chromatin in vivo. Cells were then 
synchronized in mitosis by nocodazole and mitotic 
shake-off, and time-points taken following release 
from the drug. Based on the pattern of H2B-RFP, 
cells were classified into different mitotic phases 
and subjected to FRAP analysis. Qualitative 
analysis of the obtained data revealed no immobile 
fractions and fast fluorescence recovery in the 
bleached region for both MCM2 and MCM4 in 
cells in prophase, metaphase and anaphase. On the 
contrary, the kinetic behavior of MCM2 and 
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MCM4 was markedly different in cells in 
telophase (Figures 6B and 6C). In these cells, 
although no immobile fraction was observed, the 
initial recovery was much slower (MCM2 t1/2 = 
0.98 ± 0.09 sec and MCM4 t1/2 = 0.84 ± 0.2 sec). 
The kinetic behavior of MCM proteins in 
telophase is similar to Cdt1 and differs from MCM 
kinetics during G1. As shown in Figure 6D, the 
mobility of GFP-NLS used as control is largely 
unchanged during mitosis, with only a marginal 
decrease in mobility in telophase, in contrast to the 
pronounced retardation observed for GFP-MCM2 
and GFP-MCM4. Taken together, these data 
indicate that in late mitosis MCM proteins 
maintain transient interactions with chromatin, 
which are converted to stable interactions from 
early G1. We conclude that the two steps of MCM 
loading observed in vitro, transient association and 
stable loading, are separable by FRAP in live cells 
and transient interactions are only observable for a 
short window during telophase.  
FLIP reveals the spatial distribution of MCM 
proteins bound to chromatin - FRAP allowed an 
assessment of the timing and dynamics of MCM - 
chromatin association in live human cells. In order 
to address where within the nucleus chromatin 
association takes place and whether the topology 
of MCM-chromatin binding changes during the 
cell cycle, we employed FLIP. MCF7 cells 
expressing GFP-MCM2 were arrested either in 
mitosis by nocodazole treatment and then released 
to enter G1 phase, or in late G1 by mimosine. 
Cells in early G1 (3 hours after nocodazole 
release), in middle G1 (7 hours after nocodazole 
release) or in late G1 (mimosine block) were 
analyzed by FLIP. During FLIP, a region in the 
cell nucleus was bleached continuously in order to 
erase the fluorescence of the mobile fraction of 
GFP-MCM2. Upon completion of the bleaching 
pulses, cells were imaged and examined for 
immobile structures of GFP-MCM2. 
Representative images are shown in figure 7A. 
Inspection of the post - FLIP cells revealed 
discrete GFP-MCM2 assemblies within the 
nucleus. In early G1, GFP-MCM2 immobile 
molecules were concentrated in the nuclear 
periphery and around the nucleoli, reminiscent of 
heterochromatin localization. The same pattern 
was retained in middle G1, but in that case the foci 
were more intense, indicating that a higher 
percentage of GFP-MCM2 molecules were bound 
to chromatin. Finally, in late G1 (mimosine block) 
the relative proportion of GFP-MCM2 bound 
molecules was even higher and immobile 
structures were also observed throughout the 
nucleoplasm (Figure 7A). In order to repeat our 
analysis using a different synchronization method, 
cells expressing GFP-MCM2 were arrested in 
mitosis with monastrol and released to progress 
synchronously through G1 phase. Cells were 
analyzed by FLIP 3 hours (early G1), 8 hours 
(middle G1) and 13 hours (late G1) after the 
removal of monastrol. As depicted in Figure 7B, 
analysis of the post-FLIP images showed that in 
early and middle G1 phase there is a small fraction 
of GFP-MCM2 molecules that remains bound to 
chromatin and is predominantly concentrated in 
the heterochromatic regions. However, in late G1, 
the immobile fraction of the GFP-MCM2 
molecules is substantially higher and immobile 
structures are observed throughout the nucleus as 
well as in heterochromatin (Figure 7B), verifying 
our initial observations. In order to quantify the 
fraction of GFP-MCM2 molecules that remained 
bound to chromatin in early, middle and late G1 
phase cells, the integrated intensity of the non-
bleached part of the nucleus was measured before 
and after the bleach pulse in 10, 12 and 13 
individual cells analyzed by FLIP in early, middle 
and late G1, respectively (data not shown). The 
post-bleach over the pre-bleach value was 
calculated to determine the immobile fractions of 
the GFP-MCM2 molecules. The immobile GFP-
MCM2 fraction is larger in late G1 cells (Mean 
Imm. Frac. = 0.53 ± 0.23) than in early and middle 
G1 cells (Mean Imm. Frac. = 0.22 ± 0.16, data not 
shown). Statistical analysis of the results showed 
that this difference is highly statistically 
significant (t-test p<0.001). These data further 
support maximal loading of MCM proteins in late 
G1, as previously observed by FRAP. They also 
indicate that MCM-chromatin association is not 
homogeneous through the nucleus but shows 
subnuclear concentrations throughout G1. 
MCM foci do not colocalize with replication 
factories - We next monitored changes in MCM 
chromatin binding at the subnuclear level through 
S phase by FLIP. To this end, MCF7 cells 
expressing GFP-MCM2 were transiently 
transfected with PCNA-RFP, which marks sites of 
active DNA replication. Using this approach, cells 
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in early, middle or late S phase were identified and 
subjected to FLIP (Figure 7C). Under these 
conditions, the fluorescence of the mobile pool of 
GFP-MCM2 was depleted whereas GFP-MCM2 
molecules that were tightly anchored to chromatin 
remained unbleached and thus visible. Post-FLIP 
images revealed that bound GFP-MCM2 
molecules were concentrated in subnuclear foci 
predominantly in early S cells and to a lesser 
extent in middle S cells. In early S phase, large 
MCM2 foci were restricted in heterochromatic 
regions around the nucleus and at the nucleolar 
periphery. In middle S, although these structures 
retained their localization, they were fewer and 
smaller in size. On the contrary, no immobile 
fraction of GFP-MCM2 was detected during late S 
phase. Similar results were obtained for GFP-
MCM4 (data not shown). These observations are 
in line with the FRAP results of figures 4C and 
4D, providing further support for the gradual loss 
of MCM immobile fraction during the course of S 
phase.  
Several studies have shown that MCMs do not 
colocalize with sites of DNA synthesis 
(32,33,48,57-59). We directly compared the 
localization of GFP-MCM2 structures and PCNA 
foci after photobleaching soluble molecules by 
FLIP. As shown in figure 7B, GFP-MCM2 foci 
failed to coincide spatially with PCNA, which 
labels sites of DNA replication, consistent with 
previous studies (32,33,58). Moreover, PCNA 
appeared to be in close proximity to GFP-MCM2 
foci.  
To determine the relative time that MCMs 
proteins reside on chromatin, the localization of 
chromatin - bound MCM proteins was imaged for 
different times following FLIP. MCF7 cells 
expressing GFP-MCM2 were transiently 
transfected with PCNA-RFP. Subsequently, cells 
in G1, early S and middle S phase were selected 
and subjected to FLIP. Following FLIP, a series of 
10 images along the z-axis (z-stacks) were 
acquired for each cell. The z-stacks, which were 
collected every 5 minutes over a 2 hour period, 
were collapsed into maximum intensity projection 
images and 2D fluorescent intensity versus space 
mesh plots were generated (Figure 8A). A 
subnuclear area surrounding GFP-MCM2 foci was 
defined in each cell and the mean intensity of the 
specified region was plotted over time to ensure 
that the total intensity remained constant 
throughout the experiment and that the repeated 
imaging caused no significant recording bleaching 
(Figure 8B). The residence time of GFP-MCM2 
molecules on chromatin was estimated by plotting 
the standard deviation of the per pixel 
fluorescence intensity within the defined region, as 
a function of time (Figure 8C). As shown in figure 
8C, following FLIP the high standard deviation of 
per pixel fluorescence intensity observed arises 
from regions with high levels of bound GFP-
MCM2. The standard deviation decreased over 
time, reflecting the dissociation of GFP-MCM2 
molecules from chromatin which move and diffuse 
within the cell nucleus. As shown in figure 8C, the 
reduction in standard deviation of the intensity 
reached a minimum value within 60-80 minutes 
after FLIP. This observation indicates that GFP-
MCM2 resides on chromatin for approximately 
one hour. No significant difference was detected in 
the residence time of GFP-MCM2 molecules in 
cells in G1, early S and middle S phases (Figure 
8C). 
 
DISCUSSION 
We use here a real-time in vivo licensing assay 
to study in time and space the dynamic behavior of 
MCM proteins within live human cancer cells. Our 
analysis reveals distinct modes of MCM 
interactions with chromatin through the cell cycle: 
transient interactions in late mitosis are converted 
to stable binding during G1, while significantly 
increased loading is apparent close to the G1 to S 
phase transition followed by loss of interactions 
during S phase.  
A licensing assay in live human cells - 
Functional imaging was used to assess dynamics 
of MCM proteins within live human cells. The 
suitability of the approach to accurately report on 
the interactions of MCM proteins within cells was 
verified by several observations. Correct 
localization and expression levels comparable to 
the respective endogenous proteins were shown 
for the GFP tagged MCM proteins used, while cell 
lines stably expressing the GFP tagged MCM 
proteins exhibited similar cell cycle profiles to that 
of parental MCF7 cells. MCM2 and MCM4 GFP-
tagged proteins co-fractionated with chromatin in 
close match to the endogenous proteins and 
formed complexes with endogenous MCM 
subunits. FRAP data analysis revealed an 
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immobile fraction for MCM proteins at cell cycle 
stages when chromatin is licensed for replication 
(G1 and early S phase). Importantly, siRNA 
mediated depletion of Cdt1, a central licensing 
factor required for the loading of MCMs onto 
chromatin during G1, resulted in decreased 
immobile fractions for both GFP-MCM2 and 
GFP-MCM4 as compared to control siRNA 
treated cells. Taken together, these observations 
illustrate that mobility assessed by FRAP indeed 
reflects the binding of MCMs to chromatin in 
human cultured cells. Thus, live cell imaging 
analysis permits the study of the binding 
properties of MCM proteins with native chromatin 
in intact living human cells, serving as a molecular 
tool for the measurement of DNA licensing with 
high spatio-temporal resolution.  
Multi-step loading of MCM proteins to 
chromatin - Our analysis showed that MCM 
interactions with chromatin within live cells take 
place in multiple distinct steps. In early mitosis 
and up to anaphase, no association of MCM 
proteins with chromatin is observed and MCM 
proteins apparently freely diffuse within the cell 
nucleus, with kinetics comparable to free GFP. 
During telophase and as a nuclear envelope 
reforms, retardation in GFP-MCM2 and GFP-
MCM4 recovery becomes apparent, indicating 
transient association with chromatin. Recovery is 
however complete within a few seconds, 
suggesting that there is no stably bound 
component. This is paralleled by the behavior of 
Cdt1 which appears free to diffuse and excluded 
from chromatin up to anaphase and exhibits 
transient interactions with chromatin in telophase 
(47). In contrast to Cdt1 however, which maintains 
transient interactions with chromatin throughout 
G1, both GFP-MCM2 and GFP-MCM4 exhibit an 
immobile fraction and elevated rate of recovery of 
the mobile fraction during G1 and S phases, with 
the time of 50% fluorescence recovery (t1/2) 
ranging from 0,2 - 0,3 sec compared with 0,8 - 1 
sec in telophase, respectively. We speculate that 
during telophase, MCM proteins exchange 
dynamically on and off chromatin, probing 
continuously the genome to find appropriate 
binding sites. Upon entering G1, MCM proteins 
alter kinetic properties and a fraction of them 
becomes stably bound to chromatin. The stably 
bound fraction of MCM proteins increases 
throughout G1, suggestive of reiterative licensing. 
Maximal loading is observed at the end of the G1 
phase, just prior to the G1 to S phase transition. 
The bound fraction of MCM proteins becomes 
gradually lost during S phase, consistent with loss 
of licensing as DNA is replicated. The binding of 
MCM proteins to chromatin during G1 appears 
highly stable, consistent with previous studies 
(48). We have estimated an apparent residence 
time of 1-2 hours based on FLIP analysis, while 
earlier work indicated even longer residence times 
for MCM proteins in Chinese Hamster Ovary cells 
(48). In contrast, other components of the pre-
replication complex, such as ORC (45) and Cdt1 
(46,47), dissociate completely from chromatin 
within seconds or minutes. This is consistent with 
in vitro work in Xenopus egg (60) and yeast 
extracts (61,62), which showed that the MCM 
hexamer can be stably loaded on chromatin, while 
ORC and Cdt1 can be subsequently washed away.  
MCM recruitment can be separated from 
loading during late mitosis -  In vitro studies in 
yeast have shown MCM loading onto chromatin to 
take place in two steps: initial recruitment is 
converted to stable loading following ATP 
hydrolysis (36-38).We show here that in human 
cells MCM proteins interact transiently with 
chromatin during telophase, exhibiting kinetics 
similar to Cdt1. This is consistent with MCM 
recruitment taking place during late mitosis. A 
transiently interacting MCM component was not 
detected during G1 phase. A likely explanation for 
our inability to detect a transiently interacting 
MCM component during G1, despite indications 
for re-iterative licensing, is that during the G1 
phase recruitment of MCM proteins may be a brief 
intermediate step that quickly converts to stable 
loading and therefore a transiently interacting 
fraction is not detectable. In contrast, during late 
mitosis, stable loading of MCM proteins onto 
chromatin may not yet be permitted, and MCM 
proteins may be trapped in a transiently interacting 
state for a brief time-window, allowing dynamic 
associations to be revealed. Post-translational 
modifications of MCM proteins or other pre-
replicative complex subunits could result in 
trapping the MCM complex in a recruited but not 
yet loaded state during telophase. It is interesting 
to note that both MCM4 and Cdt1 appear hyper-
phosphorylated in mitosis and early G1 ((55) and 
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Figure 2). It is also intriguing that during telophase 
and early G1, chromosome territories within the 
nucleus are established, in parallel with 
establishment of the timing of origin firing in the 
next S phase (10).  
Work in fission yeast suggested that the 
temporal pattern of DNA licensing may determine 
and reflect the replication timing of DNA origins. 
MCM proteins were shown to bind early firing 
origins earlier in G1 compared to late firing 
origins (63). Using FLIP, we observed 
accumulation of MCMs at late replicating 
heterochromatic regions from early G1 in human 
cells (3 hours post mitotic release) and throughout 
the G1 phase, in line with previous studies on 
fixed cells (64). This suggests that if such a 
differential timing of MCM association with late 
replicating regions takes place in human cells it is 
confined to mitotic exit and very early G1 phase. 
The majority of MCM proteins are loaded 
onto chromatin in late G1 phase - Maximal 
binding of MCM proteins with chromatin was 
observed late in G1, close to the G1 to S phase 
transition by both FRAP and FLIP analysis. While 
a small fraction of MCM proteins are stably bound 
to chromatin from early G1 phase (around 15%), 
30-50% of the molecules are bound just prior to S-
phase onset. While we cannot exclude that 
maximal binding is due to a gradual loading of 
MCM proteins during the course of G1, our data 
are more consistent with a wave of MCM 
chromatin loading or stabilization of MCM 
proteins on chromatin, preceding S phase entry. A 
wave of MCM loading could for example be 
enhanced through cyclin E - mediated protection 
of cdc6 from proteolysis (65) after the restriction 
point, while a stabilization of MCM proteins on 
chromatin could be linked to a decrease in Cdt1 
protein levels close to the G1 to S phase transition 
(50). Our data suggest that while licensing initiates 
at the end of mitosis, chromatin remains under-
licensed until late in G1 phase, close to the G1 to 
S-phase transition. As premature entry into S 
phase and under-licensing have been linked to 
DNA replication stress (24), gaining insight into 
the events which control multi-step MCM loading 
is important and will be facilitated by the 
functional assays presented here. 
During S phase, MCM proteins appear to 
mark unreplicated DNA regions, consistent with 
previous experiments with fixed (32,33,58) and 
live (48) cells. The gradual loss of MCM foci as S 
phase progresses supports the notion that during 
the process of DNA replication, the DNA 
replication machinery destabilizes and displaces 
MCM hexamers from chromatin. Moreover, we 
observed that the distribution of MCM foci in each 
phase resembles the characteristic pattern of 
PCNA of the following phase, in agreement with 
previous studies performed on fixed cells. In 
middle S phase, as heterochromatic regions around 
the nucleoli and at the nuclear periphery were 
being replicated, MCM foci were distinct from but 
in close proximity to PCNA foci. Previous 
analyses showed that new replication factories 
tend to form adjacent to the ones that recently 
disassembled (8). Close proximity of active 
replication factories to high concentrations of 
licensed origins could contribute to recruitment of 
released replication factors to these adjacent 
regions, consistent with a “domino” model of 
replication factory propagation (9).  
In addition to providing insight into the 
molecular mechanisms involved and the dynamics 
of DNA licensing within the mammalian cell 
nucleus, the assays described here are of potential 
practical utility.  For example, the combination of 
an in vivo licensing assay with depletion or 
overexpression of specific factors may allow the 
identification of novel factors that block or 
enhance DNA licensing. Moreover, given that 
Cdt1/Cdc6 overexpression and thus over-licensing 
of DNA has been associated with malignant 
transformation and tumorigenesis, the licensing 
system has been proposed as a novel molecular 
target for anti-cancer drug design (23,25). An in 
vivo licensing assay may offer a new approach for 
cell-based screens for the identification and 
validation of anti-tumor compounds and drugs 
under development, that will block DNA licensing 
and thus DNA replication in cancer cells. 
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FIGURE LEGENDS 
 
FIGURE 1. Characterization of MCF7 cells stably expressing GFP-MCM2, GFP-MCM4 or GFP-NLS. 
A. GFP-MCM2 and GFP-MCM4 proteins are expressed at levels similar to endogenous. Total cell 
extracts from parental MCF7 cells and cells stably expressing GFP-NLS, GFP-MCM2 or GFP-MCM4 
were analyzed by western blotting using antibodies against MCM2, MCM4, GFP and tubulin as loading 
control. B, C. GFP-MCM2 and GFP-MCM4 proteins are confined to the nucleus and are absent from the 
nucleoli. Parental MCF7 cells and cells stably expressing GFP-MCM2, GFP-NLS or GFP-MCM4 as 
indicated, were analyzed by immunofluorescence using antibodies against MCM2 (B) or MCM4 (C), 
respectively. DNA was stained with TOTO-3. D, E. Stable cells exhibit a physiological cell cycle profile. 
Cells were fixed, stained with propidium iodide and subjected to FACS analysis (D) or immunostained 
with antibodies against Cdt1, Geminin or Cyclin A and the number of cells positive for each staining was 
recorded (E). F. GFP-MCM2 and GFP-MCM4 form complexes with endogenous MCM proteins. Extracts 
from parental MCF7, stable GFP-NLS, GFP-MCM2 and GFP-MCM4 cells were prepared, 
immunoprecipitated using an antibody against GFP and immunobloted with antibodies against GFP, 
MCM2, MCM4 and MCM7. 
 
FIGURE 2. GFP-MCM2 and GFP-MCM4 bind to chromatin during G1 phase, similar to endogenous 
MCM2 and MCM4 proteins. A, B. Stable GFP-MCM2 (A) and GFP-MCM4 (B) cells were synchronized 
in M phase by nocodazole block and mitotic shake-off and cells were harvested at different time points 
(40, 50, 150, 300 and 600 minutes) as they progressed into G1 phase. Total cell extracts were prepared 
(Total) and further fractionated into a soluble (S100) and a chromatin - enriched fraction (P100) (see 
Experimental Procedures). Fractions were subjected to western blot analysis using antibodies against 
MCM2, MCM4, Cdt1. Tubulin and Commassie Brilliant Blue staining (CBB) were used as loading 
controls. 
 
FIGURE 3. Fluorescence Recovery after Photobleaching shows GFP-MCM2 and GFP-MCM4 dynamics 
in live cells. Asynchronous MCF7 cells stably expressing GFP-MCM2, GFP-MCM4, Cdt1-GFP or GFP-
NLS were analyzed by FRAP. Recovery of fluorescence in the photobleached region as a function of time 
is depicted. Immobile fraction (Imm. Frac.) and half-time (t1/2) of the recovery of the mobile fraction were 
calculated for each curve, after fitting the data as described in Experimental Procedures using easyFRAP 
(52). N represents the number of cells analyzed in each condition. Mean values are given for the 
calculated immobile fraction and half-time of recovery, with corresponding standard deviations. 
 
FIGURE 4. GFP-MCM2 and GFP-MCM4 bind to chromatin in a Cdt1-dependent manner and exhibit 
different binding properties through the cell cycle. A. Stable GFP-MCM2, GFP-MCM4 and GFP-NLS 
cells were treated with non target siRNA (siLuc) or siRNA for Cdt1 (siCdt1) followed by FRAP analysis. 
B. PCNA localization enables discrimination of different cell cycle phases. Stable GFP-MCM4 cells 
transiently transfected with PCNA-RFP were fixed and representative images of characteristic non-S and 
S phase patterns (early S, middle S and late S) were taken. C and D. Stable GFP-MCM2 (C), GFP-MCM4 
(D) and GFP-NLS cells were transiently transfected with PCNA-RFP. Cells in early, middle and late S-
phase, as well as non-S-phase cells were identified based on the localization of PCNA and analyzed  by 
FRAP. Recovery of fluorescence in the photobleached region as a function of time is depicted. Mean 
values are given for the calculated immobile fraction and half-time of recovery for all conditions tested, 
with corresponding standard deviations. N represents the number of cells analyzed for each condition.  
 
FIGURE 5. GFP-MCM2 and GFP-MCM4 display maximal binding to chromatin during late G1 phase. 
A, B. Stable GFP-MCM2 (A) and GFP-MCM4 (B) cells were synchronized in M phase by nocodazole 
block and mitotic shake off. GFP-MCM2/4 cells in early G1 (3 hours post mitotic release) and in middle 
to late G1 (9 hours post mitotic release), as well as unsynchronized stable Cdt1-GFP and GFP-NLS cells 
were analysed by FRAP. C, D. Stable GFP-MCM2 (C) and GFP-MCM4 (D) cells were synchronized in 
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late G1 after mimosine treatment (mimosine), and in early S phase by a double thymidine block 
(thymidine) or hydroxurea (HU) treatment and analysed by FRAP, in parallel to unsynchronized GFP-
MCM2/4 and GFP-NLS cells. E, F. Stable GFP-MCM2 (E) and GFP-MCM4 cells were synchronized in 
mitosis by monastrol and time points taken in early, middle and late G1 phase (at 3, 7 and 13 hours 
following release). Recovery of fluorescence in the photobleached region as a function of time is depicted 
for all conditions. G, H. Following curve fitting of individual FRAP curves, immobile fraction (Imm. 
Frac.) and half-time (t1/2) of the recovery of the mobile fraction were computed for all cells analyzed in 
panels A-F using easyFRAP (52). N represents the number of cells analyzed for each condition. Mean 
values with standard deviation are shown. 
  
FIGURE 6. GFP-MCM2/4 display transient binding during telophase. A. GFP-MCM4 is absent from 
chromatin during prophase, metaphase and anaphase, but co-localizes with chromatin during telophase. 
Stable GFP-MCM4 cells were synchronized in M phase after nocodazole block, fixed and DNA was 
stained with DAPI. B-D. Stable GFP-MCM2 (B) , GFP-MCM4 (C) and control GFP-NLS cells (D) were 
transiently transfected with a plasmid expressing H2B-RFP which marks chromosomes. Cells in the 
different stages of M phase were identified based on morphology and analyzed by FRAP. Fluorescence 
recovery is shown as a function of time. Immobile fraction (Imm. Frac.) and half-time (t1/2) of the 
recovery of the mobile fraction were computed. N represents the number of cells analyzed for each 
condition.  
 
FIGURE 7. Subnuclear distribution of chromatin - bound GFP-MCM2. A. Stable GFP-MCM2 cells were 
either synchronized in M phase after nocodazole block and mitotic shake off and released into G1 phase 
or synchronized in late G1 phase by mimosine treatment. After 3 hours (post noc 3h) and 7 hours (post 
noc 7h) following nocodazole release and  in late G1 phase (mimosine block) cells were subjected to 
FLIP analysis and representative images are shown before and after the bleaching step. B. Stable GFP-
MCM2 cells were synchronized  in mitosis by monastrol and  released  into a synchronous G1 phase. At 
3, 7 and 13 hours post release (early, middle and  late G1 phase respectively) cells were analyzed by 
FLIP. Pre and post-bleach  images are shown for representative cells. C. GFP-MCM2 does not colocalize 
with PCNA foci in the various stages of S phase. Stable GFP-MCM2 cells were transiently transfected 
with PCNA-RFP. Cells were discriminated according to PCNA patterning, FLIP was carried out and 
representative images were taken. Cells before bleaching are displayed on the left (pre bleach) and cells 
after bleaching are displayed on the right (post bleach). In all panels, the bleached regions are marked by 
a red line in the post-bleached images. In panels A and B, red arrowheads indicate immobile structures of 
GFP-MCM2. In panel C, part of the post-bleach  images in early and  middle - S cells has been blown up 
(red squares) to highlight the lack of colocalization between PCNA and GFP-MCM2 foci. The difference 
in fluorescence intensity between panels A and B is due to differences in recording and bleaching 
conditions. 
 
FIGURE 8. GFP-MCM2 resides on chromatin for approximately 60 to 80 minutes. A. Stable GFP-
MCM2 cells were transiently transfected with a plasmid expressing PCNA-RFP. Cells in G1, early S and 
middle S phase were identified according to PCNA patterning and subjected to FLIP. Z-stack sections of 
each cell’s volume were captured every 5 minutes for a total duration of 2 hours and mesh plots were 
created as described in Experimental Procedures. A subnuclear area of each cell containing GFP-MCM2 
foci was defined (red boxes) and the fluorescence intensity (B) as well as the corresponding standard 
deviation (C) were plotted throughout the course of the experiment.  
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